Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Anticoagulants are the standard treatment for cerebral venous thrombosis (CVT). Although low-molecular-weight heparin (LMWH) is recommended in CVT, the specific type and dosage regimen of LMWH have never been specifically suggested. This study compared the clinical outcomes and adverse events in patients who received adjusted-dose unfractionated heparin (AD-UFH) versus fixed-dose enoxaparin (FD-E).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Neurol Neurosurg

Title: Clinical neurology and neurosurgery

Publisher: Elsevier BV

ISSN (Electronic): 1872-6968

ISSN (Print): 0303-8467

Publication date (Electronic): May 10 2017

Volume: 159

Affiliations

[1 ] Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand. Electronic address: patosk120@gmail.com.

[2 ] Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

[3 ] Department of Surgical Nursing, Faculty of Nursing, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

[4 ] Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

Article

Publisher Item ID: S0303-8467(17)30142-7

DOI: 10.1016/j.clineuro.2017.05.012

PubMed ID: 28535419

SO-VID: 07145c2c-b7ad-4a03-8ef7-2b271c7882c0

History

Keywords: Cerebral venous thrombosis,Efficacy,Enoxaparin,Unfractionated heparin

Data availability:

Keywords: Cerebral venous thrombosis, Efficacy, Enoxaparin, Unfractionated heparin

Comments

Comment on this article

scite_